Strategic Acquisition Intrasphere Technologies was acquired by Deloitte, signaling a strategic shift toward integrated life sciences R&D and regulatory services. This creates cross-sell opportunities for Deloitte’s global clients and potential expansion of Intrasphere’s drug safety and regulatory offerings within larger enterprise accounts.

Regulatory & Safety Focus Strengthen outreach to life sciences customers seeking drug safety, pharmacovigilance, and regulatory compliance solutions, leveraging the PharmaCM platform as a differentiator to integrate content management with safety analytics.

Mid-Sized Scale With 11-50 employees and $25M-$50M in revenue, target midsize pharma and biotech firms that require specialized regulatory consulting and scalable risk management without the complexity of a large multinational firm.

Cloud-Native Tech Reference the use of Nginx in the tech stack to position capabilities in scalable web services, secure deployments, and API-driven integrations to support pharmacovigilance systems and regulatory data workflows.

Cross-Sell Potential Leverage Deloitte’s client base and Intrasphere’s platform to cross-sell integrated regulatory consulting, drug safety services, and content management solutions to life sciences customers seeking end-to-end compliance and data governance.